William Young
Physician Assistant · Greenville, SCNPI 1649815036
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $73,431 of the $117,257 with a category attached, or 62.6%. Johnson & Johnson accounts for 94.1% of it on its own, with 29 other manufacturers making up the rest. 2025 is the largest year on record at $90,775, more than ten times the $159 reported in 2021. Among physician assistant clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 511 payments — averaging $229.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$110K
- AbbVie$3K
- Takeda Pharmaceuticals U.S.A., Inc.$535
- Sanofi$465
- Ardelyx, Inc.$402
- Madrigal Pharmaceuticals$348
- plus $2K from 24 others
What the payments were for
- Consulting fees$4,4634%
- Speaking & faculty fees$73,43163%
- Travel & lodging$26,92823%
- Food & beverage$12,34011%
- Education$950%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 198 | $110,349 |
| AbbVie | 116 | $2,705 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $535 |
| Sanofi | 20 | $465 |
| Ardelyx, Inc. | 19 | $402 |
| Madrigal Pharmaceuticals | 11 | $348 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $250 |
| Janssen Scientific Affairs, LLC | 6 | $208 |
| Lilly USA, LLC | 6 | $200 |
| Ipsen Biopharmaceuticals, Inc | 9 | $193 |
| Aimmune Therapeutics, Inc. | 23 | $188 |
| Regeneron Healthcare Solutions, Inc. | 6 | $176 |
| Pfizer | 11 | $173 |
| Gilead | 8 | $159 |
| Alnylam Pharmaceuticals Inc. | 7 | $155 |
| Intercept Pharmaceuticals, Inc. | 8 | $150 |
| QOL Medical, LLC | 5 | $129 |
| E.r. Squibb & Sons, L.L.C. | 1 | $98 |
| Bristol Myers Squibb | 5 | $74 |
| Mallinckrodt Hospital Products Inc. | 2 | $45 |
| Biocon Biologics Inc | 2 | $44 |
| Organon | 2 | $41 |
| Celltrion USA Inc. | 2 | $31 |
| Vibrant Gastro, Inc. | 1 | $31 |
| Fresenius Kabi USA, LLC | 1 | $21 |
| Merck | 1 | $19 |
| Boehringer Ingelheim | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Braintree Laboratories, Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$117,257 in reported general payments places this provider in the 95th percentile of 1,852 physician assistant providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 39 | $1,060,348 |
| Skyrizi On-BodyRisankizumab-Rzaa | 32 | $666,364 |
| CreonLipase/Protease/Amylase | 58 | $188,361 |
| RinvoqUpadacitinib | 17 | $119,054 |
| XifaxanRifaximin | 23 | $79,095 |
| LinzessLinaclotide | 36 | $28,490 |
| MotegrityPrucalopride Succinate | 17 | $8,753 |
| MotofenDifenoxin Hcl/Atropine Sulfate | 12 | $8,096 |
| Budesonide EcBudesonide | 25 | $5,778 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 71 | $4,895 |
| Colestipol Hcl | 40 | $4,595 |
| Mesalamine | 15 | $4,199 |
| Sucralfate | 52 | $3,791 |
| Budesonide DrBudesonide | 20 | $3,431 |
| CholestyramineCholestyramine (With Sugar) | 24 | $2,132 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $110,349 | $1,060,34839 claims |
| AbbVieCreon, Rinvoq, Linzess | $2,705 | $335,905111 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $250 | $79,09523 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $535 | $8,75317 claims |
| Braintree Laboratories, Inc.Motofen | $16 | $8,09612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,852 physician assistant providers in South Carolina.
Other physician assistant in Greenville
- Jessica GriffithsGreenville$45K
- Jack SizemoreGreenville$17K
- Jordan GaucherGreenville$10K
- Joshua TuckerGreenville$10K
- Jenifer PetersGreenville$10K
- Christine KoopGreenville$9K
- Hannah HeusingGreenville$9K
- Benjamin AddyWest Columbia$377K
- Michael OvercashCharleston$210K
- Allison LesterMt Pleasant$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.